Metraipolis › archive › dc_460bcdac79dd

Anlotinib plus PD-1 inhibitor in advanced soft tissue sarcoma: a real-world study on treatment patterns and treatment-emergent hypothyroidism — Europe PMC PMID:42798570

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42798570
DOI: 10.3389/fimmu.2026.1949174
License (as archived): solo-consultazione
Archived: 2026-10-10T05:44:56.819Z
SHA-256 of the archived text: 05b240f5258c9264f262341544c4804a3254aaf60274956ac65797412f7755b8
Stable URL of this page: https://metraipolis.com/documento/dc_460bcdac79dd

How to cite

Anlotinib plus PD-1 inhibitor in advanced soft tissue sarcoma: a real-world study on treatment patterns and treatment-emergent hypothyroidism — Europe PMC PMID:42798570 — Europe PMC (en), https://europepmc.org/article/MED/42798570 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_460bcdac79dd (Metraipolis archive dc_460bcdac79dd, sha256 05b240f5258c9264f262341544c4804a3254aaf60274956ac65797412f7755b8)

BibTeX

@misc{dc460bcdac79dd,
  title = {Anlotinib plus PD-1 inhibitor in advanced soft tissue sarcoma: a real-world study on treatment patterns and treatment-emergent hypothyroidism — Europe PMC PMID:42798570},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42798570},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_460bcdac79dd; sha256 05b240f5258c9264f262341544c4804a3254aaf60274956ac65797412f7755b8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42798570. Agents can read the archived copy with the MCP tool read_document.